Concepedia
Statistics
Publications
5
Citations
683
H-Index
Active since
2021
Affiliations
University of Pennsylvania(Current)
La Jolla Institute for Immunology
University of California, San Francisco
Translational Therapeutics (United States)
Parker Institute for Cancer Immunotherapy
Mihir Kakara is an author at University of Pennsylvania specializing in immunology, autoimmunity, and immunotherapy.
Publications per year
2021–2023
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
Sokratis A. Apostolidis, Mihir Kakara, Mark M. Painter et al. · Nature Medicine · 2021 · 543 citations · Full text
Life Sciences, Immunology, Pathology +17
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
Koji Shinoda, Rui Li, Ayman Rezk et al. · Proceedings of the National Academy of Sciences · 2023 · 58 citations · Full text
Life Sciences, Immunology, Neurology +15
Altered cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
Sokratis A. Apostolidis, Mihir Kakara, Mark M. Painter et al. · medRxiv · 2021 · 39 citations · Full text
Life Sciences, Immunology, Pathobiology +17
<scp>Anti‐CD20</scp> monoclonal antibody therapy in postpartum women with neurological conditions
Annika Anderson, William Rowles, Shane Poole et al. · Annals of Clinical and Translational Neurology · 2023 · 27 citations · Full text
Pharmacy, Immunology, Pharmacotherapy +17
The elimination of circulating Epstein-Barr virus infected B cells underlies anti-CD20 monoclonal antibody activity in multiple sclerosis: A hypothesis
Joseph R. Berger, Mihir Kakara · Multiple Sclerosis and Related Disorders · 2022 · 16 citations
1–5 of 5